126 related articles for article (PubMed ID: 2969953)
1. Continuous subcutaneous lisuride infusions in Parkinson's disease.
Critchley PH; Grandas Perez F; Quinn NP; Parkes JD; Marsden CD
J Neural Transm Suppl; 1988; 27():55-60. PubMed ID: 2969953
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease.
Obeso JA; Luquin MR; Vaamonde J; Martînez Lage JM
J Neural Transm Suppl; 1988; 27():17-25. PubMed ID: 2969951
[TBL] [Abstract][Full Text] [Related]
3. Lisuride infusion pump in Parkinson's disease. A report of two cases.
Gershanik OS; Scipioni O; García S
J Neural Transm Suppl; 1988; 27():85-90. PubMed ID: 2969955
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Parkinson's disease with subcutaneous lisuride infusions.
Fernandez Pardal M; Micheli F; Gatto M; Perez y Gonzalez N
J Neural Transm Suppl; 1988; 27():75-84. PubMed ID: 2969954
[TBL] [Abstract][Full Text] [Related]
5. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
Bittkau S; Przuntek H
J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
Stocchi F; Ruggieri S; Antonini A; Baronti F; Brughitta G; Bellantuono P; Bravi D; Agnoli A
J Neural Transm Suppl; 1988; 27():27-33. PubMed ID: 3165437
[TBL] [Abstract][Full Text] [Related]
7. One year treatment with lisuride delivery pump in Parkinson's disease.
Ruggieri S; Stocchi F; Carta A; Bragoni M; Agostini C; Barbato L; Agnoli A
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):173-83. PubMed ID: 2748858
[TBL] [Abstract][Full Text] [Related]
8. Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
Obeso JA; Luquin MR; Martínez-Lage JM
Lancet; 1986 Mar; 1(8479):467-70. PubMed ID: 2869209
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
Vaamonde J; Luquin MR; Obeso JA
Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
[TBL] [Abstract][Full Text] [Related]
10. A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson's disease.
Chouza C; Caamaño JL; de Medina O; Aljanati R; Scaramelli A; Romero S
J Neural Transm Suppl; 1988; 27():61-70. PubMed ID: 3042913
[TBL] [Abstract][Full Text] [Related]
11. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
Obeso JA; Luquin MR; Martínez Lage JM
Ann Neurol; 1986 Jan; 19(1):31-5. PubMed ID: 3947037
[TBL] [Abstract][Full Text] [Related]
12. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
[TBL] [Abstract][Full Text] [Related]
13. Long-term observation of chronic subcutaneous administration of lisuride in the treatment of motor fluctuations in Parkinson's disease.
Heinz A; Suchy I; Klewin I; Kuhn W; Klotz P; Przuntek H
J Neural Transm Park Dis Dement Sect; 1992; 4():291-301. PubMed ID: 1388700
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a low-dose subcutaneous lisuride infusion in Parkinson's disease.
Hayashi R; Tako K; Makishita H; Koyama J; Yanagisawa N
Intern Med; 1998 May; 37(5):444-8. PubMed ID: 9652898
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
Stocchi F; Ruggieri S; Vacca L; Olanow CW
Brain; 2002 Sep; 125(Pt 9):2058-66. PubMed ID: 12183351
[TBL] [Abstract][Full Text] [Related]
16. Lisuride infusion pump for Parkinson's disease.
Lancet; 1986 Aug; 2(8502):348-9. PubMed ID: 2874360
[No Abstract] [Full Text] [Related]
17. Use of ergot derivative lisuride in Parkinson's disease.
Suchy I; Horowski R
Adv Neurol; 1984; 40():515-21. PubMed ID: 6695629
[No Abstract] [Full Text] [Related]
18. Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease.
Capria A; Attanasio A; Quatrana M; Cannata D; Fioravanti M; Stocchi F; Ruggieri S
Clin Neuropharmacol; 1989 Aug; 12(4):331-8. PubMed ID: 2804995
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients.
Vaamonde J; Luquin MR; Obeso JA
Brain; 1991 Feb; 114 ( Pt 1B)():601-17. PubMed ID: 2004258
[TBL] [Abstract][Full Text] [Related]
20. Lisuride infusion pump for Parkinson's disease.
Lancet; 1986 May; 1(8490):1150-1. PubMed ID: 2871399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
